GILEAD SCIENCES INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
GILD$170.87+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Net income: | $480 | $5,613 | $4,566 |
| Other comprehensive income (loss), net of reclassifications and taxes: | |||
| Net (loss) gain on foreign currency translation | (26) | 60 | (11) |
| Net gain (loss) on available-for-sale debt securities | 5 | 28 | (29) |
| Net gain (loss) on cash flow hedges | 125 | (62) | (41) |
| Other comprehensive income (loss), net | 104 | 26 | (81) |
| Comprehensive income, net | 584 | 5,639 | 4,485 |
| Comprehensive loss attributable to noncontrolling interest, net | — | (52) | (26) |
| Comprehensive income attributable to Gilead, net | $584 | $5,691 | $4,511 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.